LOGC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Also see: LOGC Shares Outstanding History and LOGC YTD Return |
LOGC Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||
Also see: LOGC Shares Outstanding History and LOGC YTD Return |
LOGC Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||
-26.51% CAGR Mouse over chart for data details
|
LOGC Stock Price Chart |
About LogicBio Therapeutics Inc |
LogicBio Therapeutics is a clinical-stage genetic medicine company focused on genome editing and gene delivery platforms to address diseases from infancy through adulthood. Co.'s genome editing platform, GeneRide, is an approach to gene insertion harnessing a cell's natural deoxyribonucleic acid repair process. Co.'s product candidate, LB-001, is a single-administration, genome editing therapy developed using its GeneRide technology for the treatment of methylmalonic acidemia in pediatric patients. Co.'s other product candidate, LB-401 is based on its GeneRide technology. LB-401 is a genome editing therapy being developed for the treatment of hereditary tyrosinemia type 1 in newborns. We show 19 historical shares outstanding datapoints in our LOGC shares outstanding history coverage, used to compute LOGC market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing LOGC market cap history over the course of time is important for investors interested in comparing LOGC's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of LOGC versus a peer is one thing; comparing LOGC market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like LOGC can fluctuate over the course of history. With this page we aim to empower investors researching LOGC by allowing them to research the LOGC market cap history. |
LOGC Current Stock Quote |
Free LOGC Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
LOGC Share Performance |
Market Cap Peers |
LogicBio Therapeutics (LOGC) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
LOXO Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.